Search the GHTC website
May 26, 2023

Malaria in the first trimester of pregnancy: Protecting women through research

Medicines for Malaria Venture highlights the importance of enrolling pregnant women in their first trimester in clinical trials for malaria drugs to ensure their needs are met through research.

February 13, 2023

Research Roundup: Antibiotic for sepsis, Bird flu outbreak, Rising fungal infections and resistance

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

October 17, 2022

Developing new antimalarial drugs for malaria-free pregnancies

The 2022 World Health Summit, taking place from October 16 to 18, brings together scientific, political, private, and civil society sectors to discuss the achievement of health for all. It is an opportunity to draw attention to the fact that pregnant women are underserved by currently available antimalarial therapies. Medicines for Malaria Venture (MMV), through its Malaria in mothers and babies (MiMBa) strategy, is working with partners to close critical gaps in the availability of well-tolerated malaria prevention and treatment methods for pregnant women to achieve true health for all. 
September 20, 2022

World Contraception Day 2022 quiz: Name that contraceptive method

How much do you know about the history of contraceptive innovation? Take GHTC's World Contraception Day quiz to test your knowledge.